267 Publications (Page 5 of 11)
2010
Systemic Delivery of an Oncolytic Adenovirus Expressing Soluble Transforming Growth Factor-β Receptor II–Fc Fusion Protein Can Inhibit Breast Cancer Bone Metastasis in a Mouse Model
Hu, ZebinZhang, ZhenweiGuise, Theresa and Seth, Prem
Human gene therapy, vol. 21, (no. 11), pp. 1629, 2010-Nov. | Journal Article
 
Tgf-Beta pathway as a therapeutic target in bone metastases.
Juárez, Patricia and Guise, Theresa A
Current pharmaceutical design, vol. 16, (no. 11), pp. 1301-1312, 2010. | Journal Article
 
TGF-β Pathway as a Therapeutic Target in Bone Metastases
Juarez, Patricia and Guise, Theresa
Current Pharmaceutical Design, vol. 16, (no. 11), pp. 1312, 2010-April. | Journal Article
 
Understanding and optimizing bone health in breast cancer.
Guise, Theresa ABrufsky, Adam and Coleman, Robert E
Current medical research and opinion, vol. 26 Suppl 3, pp. 3-20, 2010/Dec. | Journal Article
2009
Agents targeting prostate cancer bone metastasis.
Mohammad, Khalid SFournier, Pierrick GGuise, Theresa A and Chirgwin, John C
Anti-cancer agents in medicinal chemistry, vol. 9, (no. 10), pp. 1079-88, 2009/Dec. | Journal Article
 
Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases.
Guise, Theresa A
Genes & development, vol. 23, (no. 18), pp. 2117-23, 2009/Sep/15. | Journal Article
 
Cancer treatment-related bone disease
Brown, Sue A and Guise, Theresa A
Critical reviews in eukaryotic gene expression, vol. 19, (no. 1), pp. 60, 2009-00-00. | Journal Article
 
Cancer treatment-related bone disease.
Brown, Sue A and Guise, Theresa A
Critical reviews in eukaryotic gene expression, vol. 19, (no. 1), pp. 47-60, 2009. | Journal Article
 
Cancer Treatment-Related Bone Disease
Brown, Sue A and Guise, Theresa A
Critical Reviews™ in Eukaryotic Gene Expression, vol. 19, (no. 1), pp. 60, 2009-00-00. | Journal Article
 
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.
Dunn, Lauren KMohammad, Khalid SFournier, Pierrick GMcKenna, C RDavis, Holly WNiewolna, MariaPeng, Xiang HChirgwin, John C and Guise, Theresa A
PloS one, vol. 4, (no. 9), pp. e6896, 2009. | Journal Article
 
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
Dunn, LaurenMohammad, KhalidFournier, PierrickDavis, HollyNiewolna, MariaHong, XiangChirgwin, John and Guise, Theresa
PLoS One, vol. 4, (no. 9), Sep 2009. | Journal Article
 
Molecular biology and therapeutics in musculoskeletal oncology.
Guise, Theresa AO'keefe, Regis JRandall, R. L and Terek, Richard
The Journal of bone and joint surgery. American volume, vol. 91, (no. 3), pp. 724-32, 2009/Mar/1. | Journal Article
 
Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone.
Mohammad, Khalid SChen, Carol GBalooch, GuiveStebbins, ElizabethMcKenna, C RDavis, HollyNiewolna, MariaPeng, Xiang HNguyen, Daniel HIonova-Martin, Sophi SBracey, John WHogue, William RWong, Darren HRitchie, Robert OSuva, Larry JDerynck, RikGuise, Theresa A and Alliston, Tamara
PLoS ONE, vol. 4, (no. 4), pp. e5275, 2009. | Journal Article
 
Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
Mohammad, K.S.Mohammad, KhalidMohammad, K.S.Chen, C.G.Chen, C.G.Chen, CarolBalooch, G.Balooch, G.Balooch, GuiveStebbins, E.Stebbins, ElizabethStebbins, E.McKenna, C.R.McKenna, C.R.McKenna, C.R.McKenna, C.R.McKenna, C.R.McKenna, C.R.McKenna, C.R.McKenna, C.R.McKenna, C.R.McKenna, C.R.McKenna, C.R.Davis, H.Davis, H.Davis, HollyNiewolna, MariaNiewolna, M.Niewolna, M.Peng, X.H.Hong, XiangPeng, X.H.Peng, X.H.Peng, X.H.Peng, X.H.Peng, X.H.Peng, X.H.Peng, X.H.Peng, X.H.Peng, X.H.Peng, X.H.Nguyen, DanielNguyen, D.H.N.Nguyen, D.H.N.Ionova-Martin, S.S.Ionova-Martin, S.S.Ionova-Martin, SophiBracey, J.W.Bracey, JohnBracey, J.W.Hogue, WilliamHogue, W.R.Hogue, W.R.Wong, D.H.Wong, DarrenWong, D.H.Ritchie, R.O.Ritchie, R.O.Ritchie, RobertSuva, L.J.Suva, LarrySuva, L.J.Derynck, RikDerynck, R.Derynck, R.Guise, T.A.Guise, T.A.Guise, TheresaAlliston, T.Alliston, T. and Alliston, Tamara
PLoS One, vol. 4, (no. 4), Apr 2009. | Journal Article
 
RANKL: Targeting bone and cancer to treat skeletal complications of malignancy
Crook, Margaret K and Guise, Theresa A
IBMS BoneKEy, vol. 6, (no. 9), pp. 338, 2009-09-00. | Journal Article
 
The critical role of the bone microenvironment in cancer metastases.
Casimiro, SandraCasimiro, SandraGuise, Theresa AGuise, Theresa AChirgwin, John and Chirgwin, John
Molecular and cellular endocrinology, vol. 310, (no. 1-2), pp. 71-81, 2009/Oct/30. | Journal Article
2008
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.
Coleman, Robert EColeman, R.E.Guise, Theresa AGuise, T.A.Lipton, A.Lipton, AllanRoodman, G DRoodman, G.D.Berenson, James RBerenson, J.R.Body, J.-J.Body, Jean-JacquesBoyce, B.F.Boyce, Brendan FCalvi, Laura MCalvi, L.M.Hadji, P.Hadji, PeymanMcCloskey, Eugene VMcCloskey, E.V.Saad, FredSaad, F.Smith, M.R.Smith, Matthew RSuva, L.J.Suva, Larry JTaichman, R.S.Taichman, Russell SVessella, R.L.Vessella, Robert LWeilbaecher, K.N. and Weilbaecher, Katherine N
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 14, (no. 20), pp. 6387-95, 2008/Oct/15. | Journal Article
 
Antitumor effects of bisphosphonates: promising preclinical evidence.
Guise, Theresa A
Cancer treatment reviews, vol. 34 Suppl 1, pp. S19-24, 2008. | Journal Article
 
Assessing new bone formation in neonatal calvarial organ cultures.
Mohammad, Khalid SChirgwin, John C and Guise, Theresa A
Methods in molecular biology (Clifton, N.J.), vol. 455, pp. 37-50, 2008. | Journal Article
 
Molecular mechanisms and treatment of bone metastasis
Clines, Gregory and Guise, Theresa
Expert Reviews in Molecular Medicine, vol. 10, (no. 7), pp. e7, Mar 2008. | Journal Article
 
OC12. Specific inhibition of the VEGF homolog placental growth factor is protective against osteolytic bone metastasis in mice
Coenegrachts, LieveMaes, ChristaTorrekens, SophieVan Looveren, RietMazzone, MassimilianoGuise, TheresaBouillon, RogerCarmeliet, Peter and Carmeliet, Geert
Cancer Treatment Reviews, vol. 34, pp. 11, 2008. | Journal Article
 
P16. Hypoxia and breast cancer bone metastasis: HIF-1α enhances TGF-β signaling and expression of prometastatic factors CXCR4 and VEGF
Kingsley, LaurenKingsley, LaurenFournier, PierrickFournier, PierrickChirgwin, JohnChirgwin, JohnGuise, Theresa and Guise, Theresa
Cancer Treatment Reviews, vol. 34, pp. 18, 2008. | Journal Article
 
P32. Transforming growth factor-β (TGF-β) promotes prostate cancer bone metastases: Increased expression of pro-osteolytic genes and of PMEPA1, a new TGF-β signalling regulator
Fournier, PierrickFournier, PierrickClines, GregoryClines, GregoryChirgwin, JohnChirgwin, JohnGuise, Theresa and Guise, Theresa
Cancer Treatment Reviews, vol. 34, pp. 25, 2008. | Journal Article
 
P38. RANKL plays a role in migration and invasion of the bone-seeking cell line MDA-MB-231-BO2 and regulates MMP1 and MMP9 expression
Casimiro, SandraAlho, IrinaFernandes, AfonsoLipton, AllanGuise, Theresa and Costa, Luis
Cancer Treatment Reviews, vol. 34, pp. 28, 2008. | Journal Article
 
P48. Transforming growth factor β receptor I kinase inhibitor and bisphosphonates are additive to reduce breast cancer bone metastases
Mohammad, KhalidMohammad, KhalidStebbins, ElizabethStebbins, ElizabethKingsley, LaurenKingsley, LaurenFournier, PierrickFournier, PierrickNiewolna, MariaNiewolna, MariaMcKenna, ChristopherMcKenna, ChristopherPeng, XianhongPeng, XianhongHiggins, LindaHiggins, LindaWong, DarrenWong, DarrenGuise, Theresa and Guise, Theresa
Cancer Treatment Reviews, vol. 34, pp. 38, 2008. | Journal Article